BRD4 and nonpapillary renal cell carcinoma: Although studies associating BRD4 and CIITA genes with PRCC patient survival have not yet been reported, previous studies on CCRCC patients have reported that overexpression of BRD4 (p = 0.0003) and CIITA (p = 0.037) genes is associated with lower survival rates [28,29].